pI: 12.2586 |
Length (AA): 76 |
MW (Da): 9129 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 46 | 1vq8 (1) | 9 | 54 | 42.00 | 0.0000000045 | 0.89 | 1 | 0.74 |
1 | 46 | 1vq8 (1) | 8 | 54 | 41.00 | 0 | 0.86 | 0.955963 | 0.97 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_126918)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G52300 | 60S ribosomal protein L37-2 |
Arabidopsis thaliana | AT1G15250 | 60S ribosomal protein L37-1 |
Arabidopsis thaliana | AT3G16080 | 60S ribosomal protein L37-3 |
Babesia bovis | BBOV_III004310 | 60S ribosomal protein L37e, putative |
Brugia malayi | Bm1_15745 | 60S ribosomal protein L37-A |
Caenorhabditis elegans | CELE_C54C6.1 | Protein RPL-37 |
Caenorhabditis elegans | CELE_W01D2.1 | Protein W01D2.1 |
Cryptosporidium hominis | Chro.20237 | ribosomal protein L37e |
Cryptosporidium parvum | cgd2_2200 | 60S ribosomal protein L37 |
Dictyostelium discoideum | DDB_G0285971 | ribosomal protein L37 |
Drosophila melanogaster | Dmel_CG9091 | Ribosomal protein L37a |
Drosophila melanogaster | Dmel_CG9873 | Ribosomal protein L37b |
Echinococcus granulosus | EgrG_000183700 | ribosomal protein L37a |
Entamoeba histolytica | EHI_156690 | 60S ribosomal protein L37 |
Entamoeba histolytica | EHI_048990 | 60S ribosomal protein L37 |
Entamoeba histolytica | EHI_025600 | 60S ribosomal protein L37, putative |
Entamoeba histolytica | EHI_015320 | 60S ribosomal protein L37 |
Entamoeba histolytica | EHI_158270 | 60S ribosomal protein L37 |
Echinococcus multilocularis | EmuJ_000183700 | ribosomal protein L37a |
Giardia lamblia | GL50803_14171 | Ribosomal protein L37 |
Homo sapiens | 6167 | ribosomal protein L37 |
Leishmania braziliensis | LbrM.34.5040 | 60S ribosomal protein L37 |
Leishmania donovani | LdBPK_332070.1 | 60S ribosomal protein L37 |
Leishmania infantum | LinJ.35.5420 | 60S ribosomal protein L37 |
Leishmania infantum | LinJ.33.2070 | 60S ribosomal protein L37 |
Leishmania major | LmjF.33.1955 | 60S ribosomal protein L37 |
Leishmania major | LmjF.35.5100 | 60S ribosomal protein L37 |
Leishmania mexicana | LmxM.32.1955 | 60S ribosomal protein L37 |
Leishmania mexicana | LmxM.34.5100 | 60S ribosomal protein L37 |
Loa Loa (eye worm) | LOAG_02185 | 60S ribosomal protein L37-A |
Mus musculus | ENSMUSG00000041841 | ribosomal protein L37 |
Mus musculus | 100502825 | predicted gene 13826 |
Neospora caninum | NCLIV_015990 | hypothetical protein |
Oryza sativa | 4344579 | Os08g0128500 |
Oryza sativa | 4328048 | Os02g0111700 |
Oryza sativa | 9267955 | Os02g0815001 |
Onchocerca volvulus | OVOC11013 | 60S ribosomal protein L37 homolog |
Plasmodium berghei | PBANKA_0804000 | 60S ribosomal protein L37, putative |
Plasmodium falciparum | PF3D7_0706400 | 60S ribosomal protein L37 |
Plasmodium knowlesi | PKNH_0104900 | 60S ribosomal protein L37, putative |
Plasmodium vivax | PVX_087860 | 60S ribosomal protein L37, putative |
Plasmodium yoelii | PY02795 | Ribosomal protein L37e, putative |
Saccharomyces cerevisiae | YDR500C | ribosomal 60S subunit protein L37B |
Saccharomyces cerevisiae | YLR185W | ribosomal 60S subunit protein L37A |
Schistosoma japonicum | Sjp_0014990 | ko:K02922 large subunit ribosomal protein L37e, putative |
Schistosoma mansoni | Smp_035800 | 60S ribosomal protein L37 |
Schmidtea mediterranea | mk4.005517.01 | 60S ribosomal protein L37 |
Schmidtea mediterranea | mk4.015298.01 | 60S ribosomal protein L37 |
Trypanosoma brucei gambiense | Tbg972.11.3320 | 60S ribosomal protein L37, putative |
Trypanosoma brucei gambiense | Tbg972.9.5150 | 60S ribosomal protein L37, putative |
Trypanosoma brucei | Tb927.11.3000 | 60S ribosomal protein L37, putative |
Trypanosoma brucei | Tb927.9.9210 | 60S ribosomal protein L37, putative |
Trypanosoma cruzi | TcCLB.507773.34 | 60S ribosomal protein L37, putative |
Trypanosoma cruzi | TcCLB.510431.274 | 60S ribosomal protein L37, putative |
Trypanosoma cruzi | TcCLB.506885.14 | ribosomal protein L37, putative |
Toxoplasma gondii | TGME49_239330 | ribosomal protein RPL37 |
Theileria parva | TP02_0235 | 60S ribosomal protein L37, putative |
Trichomonas vaginalis | TVAG_454260 | 60S ribosomal protein L37, putative |
Trichomonas vaginalis | TVAG_432450 | 60S ribosomal protein L37, putative |
Trichomonas vaginalis | TVAG_339320 | 60S ribosomal protein L37, putative |
Trichomonas vaginalis | TVAG_067100 | 60S ribosomal protein L37, putative |
Trichomonas vaginalis | TVAG_005760 | 60S ribosomal protein L37, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.0865 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.0865 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.0865 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.0865 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.02.0500 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0500 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0500 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.0500 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C54C6.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C54C6.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C54C6.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C54C6.1 | Caenorhabditis elegans | sterile | wormbase |
CELE_W01D2.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_W01D2.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_W01D2.1 | Caenorhabditis elegans | slow growth | wormbase |
PBANKA_0804000 | Plasmodium berghei | Essential | plasmo |
TGME49_239330 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.